142 related articles for article (PubMed ID: 23037725)
21. Extramedullary relapse of acute lymphoblastic leukemia in breast: a rare presentation.
Thanka J; Krishnarathinam K; Rajendiran S
Indian J Pathol Microbiol; 2010; 53(1):155-6. PubMed ID: 20090251
[TBL] [Abstract][Full Text] [Related]
22. Integrating molecular information into treatment of childhood acute lymphoblastic leukemia--a perspective from the BFM Study Group.
Stanulla M; Cario G; Meissner B; Schrauder A; Möricke A; Riehm H; Schrappe M
Blood Cells Mol Dis; 2007; 39(2):160-3. PubMed ID: 17532236
[TBL] [Abstract][Full Text] [Related]
23. Monitoring and managing minimal residual disease in acute lymphoblastic leukemia.
Hoelzer D
Am Soc Clin Oncol Educ Book; 2013; ():290-3. PubMed ID: 23714526
[TBL] [Abstract][Full Text] [Related]
24. Transplants for the old but not for the young?--The enigma of adult ALL.
Sellar RS; Goldstone AH
Biol Blood Marrow Transplant; 2011 Jan; 17(1 Suppl):S71-5. PubMed ID: 21195314
[No Abstract] [Full Text] [Related]
25. [Treatment strategy for adult acute lymphoblastic leukemia].
Okamoto S
Rinsho Ketsueki; 2002 Jun; 43(6):427-32. PubMed ID: 12134694
[No Abstract] [Full Text] [Related]
26. [Treatment strategy for the patients with Philadelphia chromosome negative acute lymphoblastic leukemia in first remission].
Takeuchi J
Rinsho Ketsueki; 2010 Jul; 51(7):460-3. PubMed ID: 20693763
[No Abstract] [Full Text] [Related]
27. Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a metaanalysis.
Yanada M; Matsuo K; Suzuki T; Naoe T
Cancer; 2006 Jun; 106(12):2657-63. PubMed ID: 16703597
[TBL] [Abstract][Full Text] [Related]
28. The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Lee S; Kim YJ; Chung NG; Lim J; Lee DG; Kim HJ; Min CK; Lee JW; Min WS; Kim CC
Cancer; 2009 Feb; 115(3):561-70. PubMed ID: 19117346
[TBL] [Abstract][Full Text] [Related]
29. Pre-transplant minimal residual disease in children with acute lymphoblastic leukemia.
Mehta PA; Davies SM
Pediatr Blood Cancer; 2007 Jan; 48(1):1-2. PubMed ID: 16642487
[No Abstract] [Full Text] [Related]
30. Clinical relevance of MRD in children undergoing allogeneic stem cell transplantation for ALL.
Goulden N; Steward C
Best Pract Res Clin Haematol; 2002 Mar; 15(1):59-70. PubMed ID: 11987916
[TBL] [Abstract][Full Text] [Related]
31. Myeloablative allogeneic stem cell transplantation for lymphoblastic lymphoma in Sweden: a retrospective study.
Lazarevic VLj; Remberger M; Hägglund H; Hallböök H; Juliusson G; Kimby E; Malm C; Wahlin A; Omar H; Johansson JE
Am J Hematol; 2011 Aug; 86(8):709-10. PubMed ID: 21761436
[No Abstract] [Full Text] [Related]
32. Influence of transplantation regimen on prognostic significance of high-level minimal residual disease before allogeneic stem cell transplantation in children with ALL.
Schneider M; Hettinger K; Matthes-Martin S; Konrad M; Peters C; Gadner H; Panzer-Grümayer ER
Bone Marrow Transplant; 2001 Dec; 28(11):1087-9. PubMed ID: 11781621
[TBL] [Abstract][Full Text] [Related]
33. Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia.
Sramkova L; Muzikova K; Fronkova E; Krejci O; Sedlacek P; Formankova R; Mejstrikova E; Stary J; Trka J
Pediatr Blood Cancer; 2007 Jan; 48(1):93-100. PubMed ID: 16521130
[TBL] [Abstract][Full Text] [Related]
34. New approaches to acute lymphoblastic leukemia in adults: where do we go?
Hoelzer D; Gökbuget N
Semin Oncol; 2000 Oct; 27(5):540-59. PubMed ID: 11049022
[TBL] [Abstract][Full Text] [Related]
35. [Hematopoietic stem cell transplantation for adult acute lymphoblastic leukemia].
Kanda Y
Rinsho Ketsueki; 2010 Oct; 51(10):1564-72. PubMed ID: 20962491
[No Abstract] [Full Text] [Related]
36. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
[TBL] [Abstract][Full Text] [Related]
37. Rituximab can be useful as treatment for minimal residual disease in bcr-abl-positive acute lymphoblastic leukemia.
Jándula BM; Nomdedeu J; Marín P; Vivancos P
Bone Marrow Transplant; 2001 Jan; 27(2):225-7. PubMed ID: 11281397
[TBL] [Abstract][Full Text] [Related]
38. [Chemotherapy and hematopoietic stem cell transplantation for acute lymphoblastic leukemia].
Kanda Y
Nihon Rinsho; 2012 Apr; 70 Suppl 2():447-55. PubMed ID: 23133998
[No Abstract] [Full Text] [Related]
39. JSH guideline for tumors of hematopoietic and lymphoid tissues-leukemia: 3. Acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL).
Takeuchi J; Kusumoto S; Akiyama H; Kanda Y; Izutsu K
Int J Hematol; 2017 Dec; 106(6):732-747. PubMed ID: 29067593
[No Abstract] [Full Text] [Related]
40. Pre-engraftment graft-versus-host disease after allogeneic hematopoietic cell transplantation for acute leukemia.
Lee JH; Lee JH; Kim DY; Yun SC; Kim SD; Choi Y; Lee YS; Kang YA; Jeon MJ; Seol M; Lee KH
Eur J Haematol; 2011 Aug; 87(2):172-81. PubMed ID: 21599753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
